相关实验视频

Updated: Jun 25, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.1K

开发和验证HR+ HER-乳腺癌的预后诺莫图

Jie-Yu Zhou1, Cheng-Geng Pan1, Yang Ye1

  • 1Department of Thyroid and Breast Surgery, The Wenzhou Central Hospital, Wenzhou, Zhejiang, 325000, People's Republic of China.

Cancer management and research
|May 27, 2024
PubMed
概括

一个新的名图预测激素受体阳性,HER2阴性乳腺癌患者的无病生存期 (DFS). 该工具帮助临床医生做出化疗决策和患者风险评估.

关键词:
HR+ HER- 乳腺癌 - 乳腺癌化疗 化疗是一种化学疗法.诺莫格拉姆 (Nomograms) 是一个名字.预测 预测 预测 预测预后 预后 预后

更多相关视频

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

252
An R-Based Landscape Validation of a Competing Risk Model05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
343